Jan Shoenberger reviews 2 articles about wearable defibrillators and if we should discharge patients who have corenal abrasions with tetracaine. 

Olgin JE, Pletcher MJ, Vittinghoff E, et al. Wearable cardioverter–defibrillator after myocardial infarction. New England Journal of Medicine. 2018 Sep 27;379(13):1205-15.

Waldman N, Winrow B, Densie I, et al. An Observational Study to Determine Whether Routinely Sending Patients Home With a 24-Hour Supply of Topical Tetracaine From the Emergency Department for Simple Corneal Abrasion Pain Is Potentially Safe. Annals of emergency medicine. 2018 Jun 1;71(6):767-78.

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
Mobile Video (180p) 209 MB - MP4Small Video (400p) 209 MB - MP4Standard Video (720p) 1.04 GB - MP4